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Abstract
Depressive disorder is the most common mental  health problem in older people.  Health professionals mainly come into contact with 
those who are most susceptible to depression, including older people who live in residential facilities and the frail with acute or chronic 
physical illness.  Quite often, such individuals also exhibit multiple pathology. Under these circumstances, health professionals may 
have an exaggerated view of the extent of depression among the elderly, causing them to overlook depressive disorders that they 
may have developed.  Organic factors, including alcohol and iatrogenic drugs, must be ruled out in the aetiology.  Physical ill health 
must receive optimum treatment.  The choice of antidepressant drug is based on the side-effect profiles and potential drug-drug 
interactions, rather than on the degree of therapeutic efficacy. Treatment should be multimodal and multidisciplinary, with the aim of 
complete recovery and not simple improvement.  By using a range of treatments, most patients will recover, though keeping patients 
well is more difficult.  Treatment should be continued for at least 12 months. Many patients who could benefit from long-term 
maintenance therapy do not receive it.  With optimum management the prognosis is at least as good as that for any other stage of 
adult life.
 This article has been peer reviewed. Full text available at www.safpj.co.za SA Fam Pract 2008;50(4):38-43
Introduction
Doctors view depression and old age as going hand in hand.  Chronic 
ailments, losses in different spheres of life and the deaths of friends in 
one’s own peer group are seen as sufficient reasons to justify such a 
view.
Furthermore, health professionals mainly come into contact with those 
among the elderly who are most susceptible to depression, including 
older people who live in residential facilities and the frail with acute 
or chronic physical illness.  Quite often, such individuals also exhibit 
multiple pathology.  Under these circumstances, health professionals 
may have an exaggerated view of the extent of depression among 
older patients, resulting in their overlooking depressive disorders that 
may have developed.
This article covers classification, epidemiology, clinical presentation, 
management and prognostic factors of depressive disorders in the 
elderly.
Classification
The British Association of Psychopharmacology1 uses a practical 
classification system that refers to both DSM-IV2 and ICD-10 codes.3 
(See Table I.)
Any major depressive episode must exhibit sufficient symptoms to 
reach the syndromal threshold.  When patients suffer from relatively 
mild depression, the symptom count falls just below the threshold, with 
such patients often showing quite marked anxiety symptoms.4  Many 
patients with psychological reactions to stress fall in this category.  
In such patients, counselling and psychotherapy are the preferred 
treatment.  Patients with relatively mild forms of depression do not 
Classification DSM-IV Code ICD-10 Code
Major depression
Major depressive episode, 
single episode or recurrent 
episodes (296)
Depressive episode, 
severe (F32.2); moderate 
(F32.1) or mild, with at least 
five symptoms (F32.0); 
recurrent depressive 
disorder, current episode 
severe (F32.2); moderate 
(F33.1); or mild, with at 
least five symptoms (F33.0)
Milder depression
Depressive disorder, not 
otherwise specified (311)
Depressive disorder, mild 
with four symptoms (F32.0); 
recurrent depressive 
disorder, current episode 
mild, with four symptoms 
(F33.0); mixed anxiety and 
depressive disorder (F41.2)
Adjustment disorder with 
depressed mood/mixed 
anxiety and depressed 
mood (309)
Adjustment disorder: 
depressive reaction, mixed 
anxiety and depressive 
reaction (F43.2); other 
mood (affective) disorders 
(F38)
Dysthymia Dysthymia (300.4) Dysthymia (F34.1)
Table I: Classification of mood disorders4
For specific criteria for different disorders, see DSM-IV and ICD classification 
systems.2,3
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respond to antidepressant drug treatment as a rule.4  Patients should 
not be squeezed into narrow diagnostic boxes.  The clinician must 
take note of the number and severity of symptoms and the disability 
resulting from such, in order to see what impact depression has on the 
patient and what treatment will be best.
Though terms like ‘subsyndromal depression’ and ‘minor depression’ 
have no set meaning, recent naturalistic studies of mixed-aged patients 
strongly suggest that much subsyndromal depression is a result of 
incomplete recovery from a major depressive disorder.5
Dysthymia, which is a chronic depression of at least two years’ 
duration, often co-occurs with episodes of major depression.  
Adjustment disorder (a form of milder depression) usually originates in 
a major traumatic event.  The disorder is self-limiting, usually lasting 
less than six months.
Epidemiology
Between 10% and 15% of the elderly suffer from some degree of 
depressive symptomatology at any given time, but only 3% tend to 
experience a depressive episode.4  Although depressive symptoms 
(subsyndromal depression, minor depression or dysthymia) are more 
common among the elderly than among younger adults, no evidence 
suggests that depressive episodes also become more prevalent with 
advancing age.
Depression was assessed by Robert et al6 using DSM-IV criteria in an 
epidemiologically derived cohort of patients.  The researchers came 
to the conclusion that healthy older people are at no greater risk of 
depression than is anyone else.  Any apparent age effect could be 
attributed to physical health problems.
Furthermore, prevalence varies by location, with milder depression 
being found in a third of the elderly patients attending their general 
practitioner in the United Kingdom.7  Of significance is the discovery of 
a ‘significantly depressed mental state’ in almost two-fifths of residents 
in local authority homes.8
Depressive disorders in old age often coexist with cerebral disease, 
with many studies excluding such cases.4  Allen and Burns9 reviewed 
published data, calculating a prevalence of moderate to severe  
disorder in patients with Alzheimer’s disease at 20%, higher than in 
age-matched community residents.  Depression is probably more 
common in vascular, rather than Alzheimer-type, dementia.9
Clinical presentation
Previous research emphasised certain aspects of depressive disorder 
thought to typify old age,  including multiple somatic complaints, 
excessive hypochondriases, greater agitation, more frequent 
delusions, a more endogenous picture and an increased likelihood of 
confusion.4  A stereotype of depressive disorder in old age has been 
created.  Quite often such studies have been conducted solely on 
in-patients, which might reflect more severe illness and might not be 
representative of contemporary geriatric psychiatry. Few of the ‘typical’ 
features of late-life depression have withstood the scrutiny of more 
contemporary research.4  
More recent research has adopted two main approaches: first, 
comparing patients with depression in later life with younger adult 
depressives; second, comparing early-versus-late onset depressions 
in later life (60 years of age being the most commonly adopted cut-off 
point).
In terms of the first approach, the following findings have been 
reported: Blazer et al10 found that older community subjects, diagnosed 
according to DSM criteria, reported more somatic symptoms, had more 
thoughts about death, and a non-significantly increased preoccupation 
with the wish to die, compared with depressed younger persons, who 
tended to report more memory problems.  The notion of a special 
‘masked’ depression occurring in old age could not be confirmed by 
the study.
Musetti11 found no special feature differentiating the older from the 
younger group, though the older depressives tended to exhibit more 
retardation than agitation.
While Gurland’s study12 found that hypochondriases was more 
common in older people,
Brodaty13 found that the elderly depressives were more agitated, more 
severe, had more delusions, and were more ‘endogenous’ than the 
younger ones.  On comparing more homogeneous DSM-IV subgroups 
(e.g. melancholic subtypes), almost all differences disappeared.
The finding of the presence of more frequently occuring delusions in 
late-onset depression vary between studies.4  Such findings must be 
interpreted in the context that delusional depressive disorders are rare 
among elderly people.14
When early versus late age of onset in older depressed patients is 
compared, apart from the well-known lower prevalence of a family 
history of affective disorder among late-onset elderly depressives, few 
other clinical differences could be found.15
Lack of motivation and apathy are features of ‘vascular depression’, 
which is also characterised by reduced depressive ideation (such as 
guilt), increased psychomotor retardation and cognitive impairment, 
especially poor executive function.16
In terms of its clinical presentation, ‘depression is depression at any 
age’.  Several factors influence how depressive disorder presents in 
old age, including the following:
•  an overlap of physical with somatic depressive symptoms (e.g. 
reduced appetite, fatique)
• a tendency to minimise feelings of sadness
•  somatisation or disproportionate complaints associated with 
physical disorder
•  the sudden emergence of severe anxiety, obsessive-compulsive 
phenomena, hysteria, or hypochondriases in an elderly person not 
previously prone to such disorders
• deliberate self-harm (especially medically ‘trivial’ attempts)
•  ‘Pseudodementia’ (dementia of depression), where patients who 
appear demented may, in fact, be suffering from severe depression
• depression superimposed upon dementia
• the accentuation of abnormal personality traits
•  behavioural disorder such as food refusal, incontinence, screaming 
and outwardly aggressive behaviour
• late-onset alcohol dependency syndrome
Depression in the elderly is frequently associated with subtle cognitive 
dysfunction that persists in a minority, and which may reflect disruption 
of subcorticofrontal brain circuits.  However, a subgroup which is, as 
CPD Article
SA Fam Pract 2008                  Vol 50 No 440
yet, not readily characterised clinically might serve as a harbinger of 
irreversible dementia.  Practically, patients who present with obvious 
cognitive impairment when depressed (or with a Mini-Mental State 
Examination Score of below 24) should be closely followed up after 




During the assessment phase, the clinician must realise that checklists 
of symptoms, as in the DSM or ICD, may be helpful, but, as described 
earlier, several factors may significantly modify the clinical presentation 
in the older depressed patient.
The following hints may guide the clinician through pitfalls during the 
assessment phase4:
•  A comprehensive history must be obtained from the patient and 
other informants.  Important aspects that should be clarified are: 
any recent change in behaviour; a family and personal history 
of depression; a full drug and alcohol history; the treatment and 
response in previous depressive episodes; any major adverse 
life events and the previous capacity to cope with such events; 
personality traits; and the availability and quality of support 
systems.
•  A full mental state examination, a Mini-Mental State Examination (to 
exclude cognitive impairment) and a physical examination.
•  Laboratory investigations including haemoglobin and red blood 
cell indices (excluding Vitamin B12 deficiency or alcohol excess), 
folate levels, urea and electrolytes, thyroid function testing, 
with neuroimaging largely being performed to rule out a space-
occupying lesion.
•  Screening questionnaires (e.g. the Geriatric Depression Scale 
“GDS”) do not constitute a diagnosis.  Non-psychiatrically trained 
personnel who use scales should be given proper training in their 
use and adequate support.
What pharmacotherapy must the clinician prescribe?
With a host of newer antidepressants on the market, the perceptive 
remark of Gerson17  in 1985 still holds true: “……….. the choice of drug 
is based on the side-effect profiles and potential drug-drug interactions 
rather than on the degree of therapeutic efficacy”.
Alterations in pharmacodynamics and kinetics with age mean that 
many, though not all, antidepressants should be administered in lower 
dosages to patients as they grow older, keeping in mind the adage 
‘start low – go slow’.  Older people take longer to respond to treatment, 
so that an adequate trial of therapy may last up to eight weeks.
The type of depression remains an important factor when deciding 
what to prescribe:
•  For psychotic depression, combine antidepressant and 
antipsychotic drugs or ECT.18
•  For a more severe type of depression, tricyclic antidepressants are 
more effective than are selective serotonin-reuptake inhibitors.19
•  For minor depression, current antidepressants may be effective, 
although they are only indicated for major depressive disorders.
A classification of antidepressants is given in Table II.
Choosing from such a large range of antidepressants should 
entail matching the antidepressant to the patient, taking account 
of tolerability, safety, side effects, drug interactions, and contra-
indications.
Although newer antidepressants, especially the selective serotonin-
reuptake inhibitors (SSRIs), are often recommended as first-line 
treatment for depressive disorder in the elderly, it is unwise to dismiss 
the tricyclics out of hand.  The well-supervised prescribing of potentially 
lethal drugs, such as tricyclic drugs, may be indicated in certain clinical 
conditions, such as for those with a more severe type of depression.4
Diagnosing a specific category of depression requires weighing up 
whether pharmacological treatment is required.  Seeing a patient 
several times over a period of a few weeks or enlisting the help of a 
mental health care worker with assessing the patient over a period of 
time might be helpful.  An alternative to such a ‘wait and see’ approach 
involves conducting a therapeutic trial of an antidepressant.
As certain of the symptoms of bereavement overlap with those of 
depressive illness, the latter allows one to see which symptoms might 
require pharmacological treatment.  Clayton20 makes some important 
points.  First, the clinician always has a duty to relieve suffering.  
When such suffering takes the form of severe and enduring affective 
symptoms arising during bereavement, the short-term relief offered 
by pharmacotherapy might be justified.  Specific symptoms, such as 
insomnia, can be treated with an hypnotic for a few weeks, with the 
decision of whether or not to treat being based on particulars of the 
specific case.  Certain features clearly indicate depressive disorder, 
encouraging recourse to antidepressants.  First, the bereaved 
individual may have begun to make progress over the first few months, 
only to relapse for no apparent reason.  Second, the presence of 
suicidal thoughts, pervasive guilt, retardation, and ‘mummification’ 
– the maintaining of grief by keeping everything unchanged – suggests 
the presence of depressive disorder.
Building a partnership with the patient is critical, starting with an 
explanation that the depression warranting treatment with tablets is 
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Table II: Classification of antidepressants
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moral weakness.  Many patients require reassurance that the tablets 
they will be asked to take are not addictive, and that depression is not 
a sign of ‘senility’ or a harbinger of dementia. Involve them in their own 
treatment by telling them, in plain languge, why they should not expect 
immediate results.  They should agree on a plan of treatment with 
their clinician.  For example, the bereaved patient might be informed 
that antidepressants will relieve their depressive symptoms, but that 
further help to manage anxiety or to address how they deal with their 
bereavement is also indicated.  Doctors who work with the elderly form 
part of a multidisciplinary team, one of whom should be appointed to 
co-ordinate the care delivered and to act as a point of contact for the 
patient and the family.  Besides being multimodal, the treatment of later 
life depression should also be multidisciplinary.4
The next question to be asked is whether the numerous 
antidepressants available are superior to placebo and how their 
efficacy compares.  The drug trials that have so far demonstrated 
the superiority of antidepressants over placebo have mainly been 
conducted on relatively young patients.4  The published literature 
suggests that the newer drugs are as effective as the older ones, 
which is supported by a meta-analysis of antidepressants in older 
people, which concluded that efficacy was similar across all classes of 
antidepressants.21
One needs to consider how efficacious such antidepressants are for 
special patient groups.
•  Elderly patients with dementia:
  The practical message seems to be that moderate and severe 
depressive symptoms should be treated with antidepressants in 
those with dementia, though, in milder cases, with offering support 
to the patient and carers, in many cases the symptoms will improve 
within a month.4
• Depression in those living in residential and nursing homes:
  Given the high prevalence of depressive symptoms in care settings 
and the high rate of intolerance to older antidepressants, avoiding 
the older antidepressants is prudent and newer agents, such as the 
SSRIs, require caution.4
• Depression associated with general systemic disease:
  Although the newer antidepressants appear to have found a niche 
here, their advantage for physically compromised patients is not all 
that convincing.4
The clinician should be well aware of the different side effect profiles of 
the different categories of antidepressants.  A few pitfalls that may be 
encountered when prescribing antidepressants to older patients consist 
of the following:
•  The cardiotoxicity of tricyclic drugs has probably been 
exaggerated.4  Nevertheless, a tricyclic should not be administered 
to patients with a known tendency to either a tachy- or 
bradyarrhythmia; a bundle-branch block; those with abnormal 
or interval syndromes; or those whose heart failure is poorly 
controlled.4,22
•  The main problem with administering tricyclics to the elderly is 
that they often cause postural hypotension, which may lead to 
unpleasant dizziness or dangerous falls.4
•  The main metabolite of fluoxetine is clinically active, remaining 
so for approximately a week, possibly longer for older patients.  
Therefore, the drug must be discontinued for at least five weeks 
before an older monoamine oxidase inhibitor can be used.4
•  Some SSRIs (thus far fluoxetine, fluvoxamine, paroxetine and, 
to some degree, citalopram) have proved to inhibit the action of 
hepatic enzymatic oxidation (cytochrome P450 2D6-debrisoquine 
hydrochloride).  About 7% of Caucasians lack P450 2D6, due to a 
genetic mutation.  The combination of a tricyclic with an SSRI has 
proved quite popular, but is not without risk of elevating tricyclic 
levels into the toxic range.  A particular problem arises from the 
long half-lives of fluoxetine and its main metabolite.4  
If the clinican refers the older depressive patient to a psychiatrist, with 
electroconvulsive therapy (ECT) becoming a treatment option, they 
must keep the following facts in mind:
•  Since ECT was reintroduced in 1938, it has remained the 
most effective treatment of depression, with a recovery rate of 
approximately 80% in acute-phase treatment.4
•  ECT is as effective with older people as it is with any other age 
group and is effective and well tolerated in the very old.23
•  ECT is the treatment of choice for patients whose lives are 
threatened by food and/or fluid refusal, profound retardation or 
suicidal behaviour.4
• ECT is highly effective for delusional (psychotic) depression.24
•  The contraindications to ECT are relative.  If employed as a 
life-saving procedure, it may be used even in the presence of 
hazardous physical illness, though the patients’ physical condition 
should first be optimised and the anaethetist a senior clinician.
Psychological and social approaches to management
The treatment of elderly patients with depressive disorder demands 
multidisciplinary skills.13
Counselling may be appropriate for managing depressive symptoms 
accompanying change, stress, threat or loss to the individual, such as 
with bereavement.  However, the depressive disorder should first be 
optimally treated.
Cognitive-behavioural therapy (CBT) and interpersonal psychotherapy 
are the two most widely advocated forms of psychotherapy in elderly 
patients with depression, including the use of carers required to look 
after a person with dementia.  Psychotherapy is most effective when 
combined with antidepressant medication.
The family is, by far, the most important agency supporting the 
psychogeriatric patient at home.16  Beginning with the psychiatric 
history, information must be sought concerning the nature, frequency 
and quality of family interactions.  Interventions with families vary 
in complexity, with the first step being to provide straightforward 
information about the nature of the illness.  Later, more detailed 
interviews with members of the family should clarify the key family 
roles.  Formal family therapy can be offered to families with an elderly 
depressed member if it is thought that family dynamics are a factor in 
perpetuating the depressive illness.
Social aspects of management, including poor housing, poverty, high 
local rates of crime and other indices of deprivation, are important 
prognostic considerations.14
Prognosis
Poor outcome factors can be grouped in clinical features of the 
disorder and general factors.(4)
Clinical factors of the disorder include the following: a slower initial 
recovery; more severe initial depression; a duration of more than 
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two years; three or more previous episodes; a previous history of 
dysthymia; psychotic symptoms; extensive deep white matter and 
basal ganglia grey matter brain disease; and coarse brain disease (e.g. 
dementia).  General factors consist of: chronic stress associated with 
a poor environment, crime, poverty, a new physical illness, and poorly 
perceived social support.
The immediate prognosis for an episode of depressive illness in later 
life is good, though, in the longer term, only about 25% will remain 
completely well.  Such patients seem to be characterised as having 
responded well and rapidly to conventional treatments, as well as 
being notable for their physical fitness.17  For approximately 60% of all 
patients, the longer term prognosis is quite good, in that they will either 
remain well or have relapses that can be successfully treated.  About 
7–10% seem to be resistant to all conventional therapies and up to 
one-third will improve, but will be left with some disabling symptoms, 
such as anxiety and hypochondriasis.  Little is yet known about the 
latter group.4
Relapses are common and occur relatively early on: two-thirds 
occurred within the first 18 months of follow-up, according to Godber 
et al.18  Careful follow-up, especially during this period, is, therefore, 
essential.  Lastly, such naturalistic studies do not support the view that 
patients with depression have a higher than expected rate of dementia, 
which is an important point to emphasise both to patient and carer.4
The ultimate tragedy in terms of outcome, suicide, is not covered in this 
review.
Conclusions
Depressive disorder is the most common mental health problem of 
the elderly.  Diagnosis can be difficult, due to physical comorbidity, 
which can mask depression and age-associated factors that modify its 
clinical presentation.4  Organic factors, including alcohol and iatrogenic 
drugs, must be ruled out in the aetiology.  Physical ill health must be 
optimally treated.  New research suggests that brain abnormalities, 
most likely vascular in nature, contribute to the onset of depressive 
disorder in late-onset depression.  Treatment should be multimodal 
and multidisciplinary, with the aim of complete recovery and not simply 
improvement.  Persistence pays – using a range of treatments, most 
patients will recover.4  Keeping patients well is more of a challenge.  
Treatment should be continued for at least 12 months.  Many patients 
who could benefit from long-term maintenance therapy do not receive 
it.  With optimum management, the prognosis is at least as good as 
that for any other time of adult life.4  
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